Skip to Content

Flector Approval History

FDA Approved: Yes (First approved January 31, 2007)
Brand name: Flector
Generic name: diclofenac epolamine
Dosage form: Topical Patch
Company: Institut Biochimique SA
Treatment for: Pain

Flector is a transdermal patch formulation of the nonsteroidal anti-inflammatory drug diclofenac, indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions.

Development History and FDA Approval Process for Flector

DateArticle
Jan 31, 2007Approval Flector Approved - Institut Biochimique SA - Treatment for acute pain due to minor strains, sprains, and contusions.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide